AD 198
Alternative Names: N-Benzyladriamycin-14-valerateLatest Information Update: 31 Jan 2007
At a glance
- Originator University of Tennessee
- Class Cytostatic antibiotics
- Mechanism of Action Protein kinase C inhibitors; Type II DNA topoisomerase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Cancer